U.S. Food and Drug Administration — Drug Shortages (FDA)

U.S. Food and Drug Administration — Drug Shortages is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.accessdata.fda.gov

Country

United States

Notices tracked by Mederti

829

Last checked

17 Sept 2026

Latest notices from FDA

• Melphalanhydrochlorid — active, medium, since 16 Sept 2026 (source)
• Micafungin Sodium — active, medium, since 11 Sept 2026 (source)
• Cisatracurium Besylate — active, medium, since 11 Sept 2026 (source)
• Dextrose-Nacl (D5-1/2Ns) In Ns — active, critical, since 10 Sept 2026 (source)
• Imipenem And Cilastatin — active, medium, since 9 Sept 2026 (source)
• Insulin Lispro — active, critical, since 1 Sept 2026 (source)
• Glycerol 4G Suppositories (Glycerol) — active, medium, since 1 Sept 2026 (source)
• Insulin glargine — active, critical, since 1 Sept 2026 (source)
• Potassium Chloride — active, critical, since 31 Aug 2026 (source)
• Metoprolol-Succinate — active, medium, since 31 Aug 2026 (source)
• Medroxyprogesterone Acetate — active, medium, since 31 Aug 2026 (source)
• Palovarotene — active, medium, since 31 Aug 2026 (source)
• Pentostatin — active, critical, since 27 Aug 2026 (source)
• Liraglutide — active, medium, since 25 Aug 2026 (source)
• Mesalamine — active, medium, since 25 Aug 2026 (source)

Mederti is not affiliated with or endorsed by U.S. Food and Drug Administration — Drug Shortages. All notices remain the property of their publisher and are linked to the original source.